Actionable trade ideas with defined risk and time horizons.
Curated trade ideas across equities, options, and other instruments, featuring clear directional bias, time horizon, and risk considerations. Trade ideas are designed to align market context, technical structure, and risk management principles.
14,458 total articles
Home Depot's scale, free cash flow and a 2.8% dividend make it an attractive dip-buy while the macro recovery lags. Valuation is fair relative to cash generation (FCF yield ~4.6%) and the company enters an earnings window with modest growth expectations. This trade idea lays out an entry, stop and target for a mid-term swing trade tied to improving…
Meta's $60B raise for AI infrastructure accelerates a funding loop that benefits chip suppliers. Advanced Micro Devices (AMD) is already showing outsized data-center traction (data-center revenue up 107% to $6.7B) and trades at $508.17 with a market cap near $830B. This trade targets a rebound toward the 52-week high as hyperscaler spending and vis…
<p>A recent security breach at Binance has created a concentrated liquidity risk that could force Bitcoin to trade through nearby support levels. With scheduled on-chain movements and likely withdrawal activity clustered around tonight and 11/01, the market faces a near-term binary test: orderly absorption or waterfall selling. This trade idea outl…
Intel plunged roughly 26% after reporting blowout server growth but a cautious Q4 outlook. The sell-off pushed momentum indicators into deep-oversold territory on enormous volume — a classic capitulation that offers an actionable long opportunity with defined risk and favorable upside to prior support and moving averages.
Dole plc is trading at a compelling valuation with a market cap of $1.25B, a P/E of ~16.9 and P/B under 1.0. With steady revenues from global fresh-fruit and salad businesses, modest dividend yield (2.6%), and constructive technicals, a long trade sized for a mid-to-long-term horizon looks attractive. Entry at $13.00, stop $11.50, target $17.00 (18…
Expedia (EXPE) faces a genuine distribution risk from agentic AI assistants and metasearch disruption, but the stock screens as a compelling swing trade. At roughly $284, the company trades at mid-teens earnings multiples, generates sizable free cash flow and sits on an asset-light travel marketplace with advertising and B2B revenue streams. Trade …
Bloom Energy is trading well below its summer peak after a sharp rotation out of AI power names. Fundamentals are not broken: Q3 revenue hit $1.24B (+138% YoY) and management raised 2026 guidance to $4.4-4.6B. The trade is simple - buy a controlled position on weakness, size for implied execution risk, and use a stop to protect against execution or…
Deutsche Bank reported beat-and-raise Q3 results and trades below book value with a dividend yield near 3.5%. Technical momentum has turned constructive and short interest has ticked higher, creating a favorable risk/reward for a mid-term long trade. Entry, stop and target are provided with catalysts and balanced risks.
Rocket Lab’s Neutron delay knocked shares lower, but the company still sports a $2.36B backlog, 62% revenue growth and rising commercial demand. This trade idea buys the pullback around $56.82 with a long-term horizon (180 trading days), a $95 target and a $45 stop loss—playing the gap between operational execution risk and a multi-year growth runw…
SoFi reported blowout Q3 results and set a bullish 2027 revenue/EPS target that the market has not fully re-rated. With a $22.7B market cap, improving credit metrics, 17.1M members and an expanding product base, the stock looks attractively priced for a disciplined long trade. This idea lays out entry, stop and target, the core fundamental bull cas…
SoundHound AI is trading near its 52-week low while management continues to show high-single- to double-digit revenue growth. The stock offers asymmetric upside if the company converts its revenue momentum into margin improvement or shows a clear path to lower cash burn. This trade idea outlines an actionable entry, target, and stop, with a mid-ter…
Tango Therapeutics reported updated vopimetostat + RAS(ON) combination data at ESMO 2026 that show high objective response rates and durable control in MTAP-deleted, RAS-mutant pancreatic cancer. The market sold off after an ORR revision from 92% to 82% and the company announced a 14% workforce reduction and R&D reprioritization. We view the move a…
Celcuity (CELC) just added substantive Phase 3 subgroup data that strengthens the commercial narrative for REVTORPYK (gedatolisib). The market cap sits near $3.4B while the share price is less than half its 52-week high. This trade idea lays out a mid-term, structured long with an entry at the current level, a reasonable upside target, and a discip…
Ichor has been punished heavily despite accelerating revenue and clear margin improvement. With Q3 guidance pointing to 12% sequential revenue growth and gross margins targeted at 14.5-15.5%, the downside from here looks contained. This trade recommends a mid-term (45 trading days) long with a tight stop and an asymmetric reward-to-risk profile.
FTAI Aviation's Q3 2026 results and a run of commercial deals materially reduce execution risk and justify a mid-term long. The beat on earnings and revenue, a deeper United partnership, and a sizable 27-aircraft acquisition from WestJet provide tangible growth drivers. Valuation is rich but not unreasonable given asset-backed cash flows and a stro…
Ondas has assembled a meaningfully under-acknowledged revenue runway: $270M+ in orders since 6/30 and a $757M pro-forma backlog underpinning 2026 guidance of $525-$550M. Short sellers and pervasive talk of dilution have been pricing fear into the shares. This trade idea takes a contrarian, risk-aware long stance: enter $6.90, target $10.00, stop $5…
Applied Materials reported a 51% growth quarter and is trading around 23x forward earnings. The semiconductor equipment cycle is still in the early-to-middle innings, and AMAT's exposure to AI-driven capex and node transitions gives the stock asymmetric upside versus current multiple. This trade idea lays out an entry, stop, targets and the key cat…
Deckers offers a pragmatic long opportunity: strong free cash flow, expanded gross margins, and a recovering HOKA combined with international growth argue for upside from the current $83 area to a $120 target over the next 180 trading days. Entry at $83.12, stop $75.00, target $120.00.
Eli Lilly (LLY) is trading near record highs after another run driven by weight-loss, neuroscience and immunology momentum. Fundamentals remain strong — $1.29T market cap, free cash flow of $18.19B and ROE near 79% — but the stock is richly valued. This trade idea proposes a disciplined mid-term long with a clearly defined entry, stop and target to…
Dycom (DY) is a specialty contractor that has quietly become a beneficiary of the AI/data-center build cycle. Strong Building Systems profitability, a record $12.24B backlog and raised fiscal 2027 guidance argue for upside while valuation sits below peak multiples. This trade proposes a mid-term long with defined entry, stop and target to capture a…
Fluence (FLNC) has been punished hard after a guided revenue cut and disclosed production troubles. The stock is trading near its 52-week low, technical momentum is improving, and short interest has climbed — creating a backdrop for an asymmetric trade. This idea is a high-risk, event-driven buy: small starter at the market, add on constructive ope…
IREN is a vertically integrated data center operator pivoting from bitcoin mining to AI cloud capacity. Recent weakness has pushed the stock to $26.27, trading well off its $76.87 high, but the company reports $4B of contracted annualized revenue with $1B operational. Balance-sheet strain and negative cash flow are real, but current valuation and t…
First Solar's unique cadmium telluride (CdTe) technology, near-zero debt, and strong free cash flow argue for a re-rating between now and mid-2027. The market is focused on near-term revenue weakness and pushed the stock toward its 52-week low. We outline a long trade that targets a move to $230 over a 180 trading-day horizon while limiting downsid…
GSK delivered a modest Q3 beat and trades at a reasonable multiple with a 3.7% yield. Technical momentum is mixed but intact; near-term headwinds and analyst revisions create a tradeable dip. A controlled long entry around $48.50 targets $54 with a tight stop at $46 over a 45-trading-day horizon.
On Holding (ONON) has pulled back roughly 30% year-to-date amid an intentional wholesale slowdown and reset of channel inventory. Fundamentals - double-digit top-line growth, a 65%+ gross margin profile in recent reporting, and accelerating DTC - remain intact. This trade idea outlines a long entry, risk controls, catalysts to watch, and the scenar…
